US Patent 7339064 Benzimidazole compound crystal
Patent 7339064 was granted and assigned to Takeda Pharmaceutical Company on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Akira Fujishima0
Isao Aoki0
Keiji Kamiyama0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+210 characters)
Article
Patent abstract
A novel crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole or a salt thereof of the present invention is useful for an excellent antiulcer agent.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07339064 Benzimidazole compound crystal US Patent 7339064 Benzimidazole compound crystal
Infobox
Patent Number
073390640
Patent Number
73390640
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073390640
Date of Patent
March 4, 2008
0Patent Application Number
111499030
Date Filed
June 10, 2005
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07339064 Benzimidazole compound crystal
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07339064
Date of patent
March 4, 2008
Patent application number
11149903
Date Filed
June 10, 2005
Patent primary examiner
Find more entities like US Patent 7339064 Benzimidazole compound crystal
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
